Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3880815018 | Zanubrutinib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3880816017 | Zanubrutinib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4699911000052113 | zanubrutinib | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zanubrutinib | Has disposition (attribute) | Non-specific protein-tyrosine kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Zanubrutinib | Is a | Non-specific protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Zanubrutinib | Is a | Piperidine | true | Inferred relationship | Some | ||
| Zanubrutinib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Zanubrutinib | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing zanubrutinib in oral dose form (medicinal product form) | Has active ingredient | True | Zanubrutinib | Inferred relationship | Some | 1 |
| Product containing zanubrutinib (medicinal product) | Has active ingredient | True | Zanubrutinib | Inferred relationship | Some | 1 |
| Zanubrutinib only product | Has active ingredient | True | Zanubrutinib | Inferred relationship | Some | 1 |
| Product containing only zanubrutinib in oral dose form (medicinal product form) | Has active ingredient | True | Zanubrutinib | Inferred relationship | Some | 1 |
| Product containing precisely zanubrutinib 80 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Zanubrutinib | Inferred relationship | Some | 1 |
| Product containing precisely zanubrutinib 80 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | True | Zanubrutinib | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR